{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:04:51Z","timestamp":1783911891854,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10620-025-09656-x","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:43:24Z","timestamp":1768563804000},"page":"2496-2507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Qualitative Research for the Development of Three New Quality of Life and Treatment Impact Questionnaires for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)"],"prefix":"10.1007","volume":"71","author":[{"given":"Tim","family":"Vanuytsel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bolognani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighann","family":"Litcher-Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mena","family":"Boules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"9656_CR1","unstructured":"National Organization for Rare Disorders. Short Bowel Syndrome\u00a013 Sept 2019\u00a0https:\/\/rarediseases.org\/rare-diseases\/short-bowel-syndrome\/"},{"key":"9656_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clnesp.2021.07.004","volume":"45","author":"L Pironi","year":"2021","unstructured":"Pironi L, Steiger E, Joly F et al. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey. Clin Nutr ESPEN. 2021;45:433\u2013441. https:\/\/doi.org\/10.1016\/j.clnesp.2021.07.004.","journal-title":"Clin Nutr ESPEN."},{"key":"9656_CR3","unstructured":"Guillen B, S Atherton N. Short Bowel Syndrome. Accessed 2024, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536935\/"},{"key":"9656_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","volume":"35","author":"L Pironi","year":"2016","unstructured":"Pironi L, Arends J, Bozzetti F et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35:247\u2013307. https:\/\/doi.org\/10.1016\/j.clnu.2016.01.020.","journal-title":"Clin Nutr."},{"key":"9656_CR5","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","volume":"42","author":"L Pironi","year":"2023","unstructured":"Pironi L, Cuerda C, Jeppesen PB et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clin Nutr. 2023;42:1940\u20132021. https:\/\/doi.org\/10.1016\/j.clnu.2023.07.019.","journal-title":"Clin Nutr."},{"key":"9656_CR6","unstructured":"Hamdan M, Puckett Y. Total Parenteral Nutrition. StatPearls. StatPearls Publishing Copyright \u00a9 2024, StatPearls Publishing LLC.; 2024."},{"key":"9656_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/1319-3767.82573","volume":"17","author":"P Seetharam","year":"2011","unstructured":"Seetharam P, Rodrigues G. Short bowel syndrome: a review of management options. Saudi J Gastroenterol. Jul-Aug 2011;17:229\u2013235. https:\/\/doi.org\/10.4103\/1319-3767.82573.","journal-title":"Saudi J Gastroenterol. Jul-Aug"},{"key":"9656_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1021\/acsptsci.9b00016","volume":"2","author":"DJ Drucker","year":"2019","unstructured":"Drucker DJ. The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. ACS Pharmacol Transl Sci. 2019;2:134\u2013142. https:\/\/doi.org\/10.1021\/acsptsci.9b00016.","journal-title":"ACS Pharmacol Transl Sci."},{"key":"9656_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/jpen.1767","volume":"44","author":"MK Hvistendahl","year":"2020","unstructured":"Hvistendahl MK, Naimi RM, Enevoldsen LH, Madsen JL, Fuglsang S, Jeppesen PB. Effect of Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial. JPEN J Parenter Enteral Nutr. 2020;44:1535\u20131544. https:\/\/doi.org\/10.1002\/jpen.1767.","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"9656_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/MCO.0b013e32832d23cd","volume":"12","author":"K Wallis","year":"2009","unstructured":"Wallis K, Walters JR, Gabe S. Short bowel syndrome: the role of GLP-2 on improving outcome. Curr Opin Clin Nutr Metab Care. 2009;12:526\u2013532. https:\/\/doi.org\/10.1097\/MCO.0b013e32832d23cd.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"9656_CR11","doi-asserted-by":"publisher","first-page":"300060522108614","DOI":"10.1177\/03000605221086145","volume":"50","author":"C Zhu","year":"2022","unstructured":"Zhu C, Li Y. An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults. J Int Med Res. 2022;50:3000605221086145. https:\/\/doi.org\/10.1177\/03000605221086145.","journal-title":"J Int Med Res."},{"key":"9656_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0261-5614(03)00042-6","volume":"22","author":"E Carlsson","year":"2003","unstructured":"Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr. 2003;22:445\u2013452. https:\/\/doi.org\/10.1016\/S0261-5614(03)00042-6.","journal-title":"Clin Nutr."},{"key":"9656_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jpen.2223","volume":"46","author":"J Eliasson","year":"2022","unstructured":"Eliasson J, Hvistendahl MK, Freund N, Bolognani F, Meyer C, Jeppesen PB. Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo-controlled, randomized phase 2 trial. JPEN J Parenter Enteral Nutr. 2022;46:896\u2013904. https:\/\/doi.org\/10.1002\/jpen.2223.","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"9656_CR14","unstructured":"Label G. GATTEX (teduglutide [rDNA origin]), for injection, for subcutaneous use. 2012. Accessed 10\/31\/2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/203441Orig1s000lbl.pdf"},{"key":"9656_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ et al. Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1-Eliciting Concepts for a New PRO Instrument. Value in Health. 2011;14:967\u2013977. https:\/\/doi.org\/10.1016\/j.jval.2011.06.014.","journal-title":"Value in Health."},{"key":"9656_CR16","unstructured":"US Department of Health & Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Accessed 4\/22\/2025, https:\/\/www.fda.gov\/media\/77832\/download"},{"key":"9656_CR17","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input \u2013 Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. Office of Communications, Division of Drug Information; 06\/2020."},{"key":"9656_CR18","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research CfDaRH. Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders (DRAFT GUIDANCE). Office of Communications, Division of Drug Information; 02\/2022."},{"key":"9656_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MLR.0000000000000273","volume":"53","author":"EM Perfetto","year":"2015","unstructured":"Perfetto EM, Burke L, Oehrlein EM, Epstein RS. Patient-Focused Drug Development: A New Direction for Collaboration. Medical Care. 2015;53:9\u201317. https:\/\/doi.org\/10.1097\/MLR.0000000000000273.","journal-title":"Medical Care."},{"key":"9656_CR20","doi-asserted-by":"publisher","unstructured":"Baxter JP, Fayers Peter M., W. MA. The development and translation of a treatment-specific quality of life questionnaire for adult patients on home parenteral nutrition. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2008;3 https:\/\/doi.org\/10.1016\/j.eclnm.2007.10.001","DOI":"10.1016\/j.eclnm.2007.10.001"},{"key":"9656_CR21","doi-asserted-by":"publisher","unstructured":"Baxter JP, Fayers PM, McKinlay AW. The clinical and psychometric validation of a questionnaire to assess the quality of life of adult patients treated with long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 Mar-Apr 2010;34(2):131\u201342. https:\/\/doi.org\/10.1177\/0148607109348612","DOI":"10.1177\/0148607109348612"},{"key":"9656_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.clnu.2012.12.001","volume":"32","author":"P Bergh\u00f6fer","year":"2013","unstructured":"Bergh\u00f6fer P, Fragkos KC, Baxter JP et al. Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL\u2122) scale. Clin Nutr. 2013;32:789\u2013796. https:\/\/doi.org\/10.1016\/j.clnu.2012.12.001.","journal-title":"Clin Nutr."},{"key":"9656_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40265-013-0070-y","volume":"73","author":"CB Burness","year":"2013","unstructured":"Burness CB, McCormack PL. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome. Drugs. 2013;73:935\u2013947. https:\/\/doi.org\/10.1007\/s40265-013-0070-y.","journal-title":"Drugs."},{"key":"9656_CR24","doi-asserted-by":"crossref","unstructured":"Jeppesen P. Short Bowel Syndrome - characterization of an orphan condition with many phenotypes. Expert Opinion on Orphan Drugs2013.","DOI":"10.1517\/21678707.2013.814535"},{"key":"9656_CR25","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Patient-Focused Drug Development: Methods to Identify What Is Important to Patients \u2013 Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders. 02\/2022:Appendix 4."},{"key":"9656_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ et al. Content Validity - Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2-Assessing Respondent Understanding. Value in Health. 2011;14:978\u2013988. https:\/\/doi.org\/10.1016\/j.jval.2011.06.013.","journal-title":"Value in Health."},{"key":"9656_CR27","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments. Office of Communications, Division of Drug Information; 06\/2022."},{"key":"9656_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","volume":"21","author":"DM Turner-Bowker","year":"2018","unstructured":"Turner-Bowker DM, Lamoureux RE, Stokes J et al. Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development. Value in health\u202f: the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018;21:839\u2013842.","journal-title":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research."},{"key":"9656_CR29","doi-asserted-by":"publisher","unstructured":"Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. Jama. 1995;273(1):59\u201365. https:\/\/doi.org\/10.1001\/jama.1995.03520250075037","DOI":"10.1001\/jama.1995.03520250075037"},{"key":"9656_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1067\/mjw.2001.113261","volume":"28","author":"E Carlsson","year":"2001","unstructured":"Carlsson E, Berglund B, Nordgren S. Living with an ostomy and short bowel syndrome: practical aspects and impact on daily life. J Wound Ostomy Continence Nurs. 2001;28:96\u2013105. https:\/\/doi.org\/10.1067\/mjw.2001.113261.","journal-title":"J Wound Ostomy Continence Nurs."},{"key":"9656_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.clnu.2006.05.003","volume":"25","author":"JP Baxter","year":"2006","unstructured":"Baxter JP, Fayers PM, McKinlay AW. A review of the quality of life of adult patients treated with long-term parenteral nutrition. Clin Nutr. 2006;25:543\u2013553. https:\/\/doi.org\/10.1016\/j.clnu.2006.05.003.","journal-title":"Clin Nutr."},{"key":"9656_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MCO.0b013e328363bce4","volume":"57","author":"E Efsen","year":"2011","unstructured":"Efsen E, Jeppesen PB. Modern treatment of adult short bowel syndrome patients. Minerva Gastroenterol Dietol. 2011;57:405\u2013417. https:\/\/doi.org\/10.1097\/MCO.0b013e328363bce4.","journal-title":"Minerva Gastroenterol Dietol."},{"key":"9656_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1185\/03007995.2013.784700","volume":"29","author":"S Hofstetter","year":"2013","unstructured":"Hofstetter S, Stern L, Willet J. Key issues in addressing the clinical and humanistic burden of short bowel syndrome in the US. Curr Med Res Opin. 2013;29:495\u2013504. https:\/\/doi.org\/10.1185\/03007995.2013.784700.","journal-title":"Curr Med Res Opin."},{"key":"9656_CR34","doi-asserted-by":"publisher","first-page":"32S","DOI":"10.1177\/0148607113517717","volume":"38","author":"MF Winkler","year":"2014","unstructured":"Winkler MF, Smith CE. Clinical, social, and economic impacts of home parenteral nutrition dependence in short bowel syndrome. JPEN J Parenter Enteral Nutr. 2014;38:32S-37S. https:\/\/doi.org\/10.1177\/0148607113517717.","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"9656_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","volume":"32","author":"PB Jeppesen","year":"2013","unstructured":"Jeppesen PB, Pertkiewicz M, Forbes A et al. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analog teduglutide\u2013analyses from a randomised, placebo-controlled study. Clin Nutr. 2013;32:713\u2013721. https:\/\/doi.org\/10.1016\/j.clnu.2013.03.016.","journal-title":"Clin Nutr."},{"key":"9656_CR36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/0148607113512678","volume":"38","author":"DG Kelly","year":"2014","unstructured":"Kelly DG, Tappenden KA, Winkler MF. Short bowel syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014;38:427\u2013437. https:\/\/doi.org\/10.1177\/0148607113512678.","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"9656_CR37","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1053\/j.gastro.2005.09.065","volume":"130","author":"L Howard","year":"2006","unstructured":"Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology. 2006;130:S52\u2013S59. https:\/\/doi.org\/10.1053\/j.gastro.2005.09.065.","journal-title":"Gastroenterology."},{"key":"9656_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2147\/CEG.S42665","volume":"7","author":"K Vipperla","year":"2014","unstructured":"Vipperla K, O\u2019Keefe SJ. Targeted therapy of short-bowel syndrome with teduglutide: the new kid on the block. Clin Exp Gastroenterol. 2014;7:489\u2013495. https:\/\/doi.org\/10.2147\/CEG.S42665.","journal-title":"Clin Exp Gastroenterol."},{"key":"9656_CR39","doi-asserted-by":"publisher","unstructured":"Winkler MF, Hagan E, Wetle T, Smith C, Maillet JO, Touger-Decker R. An exploration of quality of life and the experience of living with home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 Jul-Aug 2010;34(4):395\u2013407. https:\/\/doi.org\/10.1177\/0148607110362582","DOI":"10.1177\/0148607110362582"},{"key":"9656_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/00365520802078325","volume":"43","author":"E Kalaitzakis","year":"2008","unstructured":"Kalaitzakis E, Carlsson E, Josefsson A, Bosaeus I. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms. Scand J Gastroenterol. 2008;43:1057\u20131065. https:\/\/doi.org\/10.1080\/00365520802078325.","journal-title":"Scand J Gastroenterol."},{"key":"9656_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3748\/wjg.v18.i5.445","volume":"18","author":"LP Jelsness-J\u00f8rgensen","year":"2012","unstructured":"Jelsness-J\u00f8rgensen LP, Bernklev T, Henriksen M, Torp R, Moum B. Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World journal of gastroenterology. 2012;18:445\u2013452. https:\/\/doi.org\/10.3748\/wjg.v18.i5.445.","journal-title":"World journal of gastroenterology."},{"key":"9656_CR42","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/s0016-5085(03)70064-x","volume":"124","author":"AL Buchman","year":"2003","unstructured":"Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1111\u20131134. https:\/\/doi.org\/10.1016\/s0016-5085(03)70064-x.","journal-title":"Gastroenterology."},{"key":"9656_CR43","doi-asserted-by":"publisher","unstructured":"Madsen KB, Askov-Hansen C, Naimi RM, et al. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept. Jun 2013;184:30\u20139. https:\/\/doi.org\/10.1016\/j.regpep.2013.03.025","DOI":"10.1016\/j.regpep.2013.03.025"},{"key":"9656_CR44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1358\/dot.2013.49.10.2017025","volume":"49","author":"PB Jeppesen","year":"2013","unstructured":"Jeppesen PB. Teduglutide for the treatment of short bowel syndrome. Drugs Today (Barc). 2013;49:599\u2013614. https:\/\/doi.org\/10.1358\/dot.2013.49.10.2017025.","journal-title":"Drugs Today (Barc)."},{"key":"9656_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gtc.2017.10.004","volume":"47","author":"PB Jeppesen","year":"2018","unstructured":"Jeppesen PB, Fuglsang KA. Nutritional Therapy in Adult Short Bowel Syndrome Patients with Chronic Intestinal Failure. Gastroenterol Clin North Am. 2018;47:61\u201375. https:\/\/doi.org\/10.1016\/j.gtc.2017.10.004.","journal-title":"Gastroenterol Clin North Am."},{"key":"9656_CR46","doi-asserted-by":"publisher","unstructured":"Iyer KR, Kunecki M, Boullata JI, et al. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome. JPEN J Parenter Enteral Nutr. 08 2017;41(6):946\u2013951. https:\/\/doi.org\/10.1177\/0148607116680791","DOI":"10.1177\/0148607116680791"},{"key":"9656_CR47","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.1177\/0148607114526241","volume":"38","author":"PB Jeppesen","year":"2014","unstructured":"Jeppesen PB. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2014;38:45S-52S. https:\/\/doi.org\/10.1177\/0148607114526241.","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"9656_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/14656566.2012.644787","volume":"13","author":"LM N\u00f8rholk","year":"2012","unstructured":"N\u00f8rholk LM, Holst JJ, Jeppesen PB. Treatment of adult short bowel syndrome patients with teduglutide. Expert Opin Pharmacother. 2012;13:235\u2013243. https:\/\/doi.org\/10.1517\/14656566.2012.644787.","journal-title":"Expert Opin Pharmacother."},{"key":"9656_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/425759","volume":"2009","author":"PB Jeppesen","year":"2009","unstructured":"Jeppesen PB, Lund P, Gottschalck IB et al. Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract. 2009;2009:425759. https:\/\/doi.org\/10.1155\/2009\/425759.","journal-title":"Gastroenterol Res Pract."},{"key":"9656_CR50","doi-asserted-by":"publisher","unstructured":"EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. Dec 1990;16(3):199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"9656_CR51","unstructured":"Ware JE, Jr., Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User's Manual for the SF-36v2\u2122 Health Survey. 2nd ed. QualityMetric Incorporated; 2007."},{"key":"9656_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4.","journal-title":"Psychiatry Res."},{"key":"9656_CR53","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/0884533617725041","volume":"32","author":"TL Miller","year":"2017","unstructured":"Miller TL, Greene GW, Lofgren I, Greaney ML, Winkler MF. Content Validation of a Home Parenteral Nutrition-Patient-Reported Outcome Questionnaire. Nutr Clin Pract. 2017;32:806\u2013813. https:\/\/doi.org\/10.1177\/0884533617725041.","journal-title":"Nutr Clin Pract."},{"key":"9656_CR54","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jpen.2040","volume":"45","author":"MF Winkler","year":"2021","unstructured":"Winkler MF, Machan JT, Xue Z, Compher C. Home Parenteral Nutrition Patient-Reported Outcome Questionnaire: Sensitive to Quality of Life Differences Among Chronic and Prolonged Acute Intestinal Failure Patients. Journal of Parenteral and Enteral Nutrition. 2021;45:1475\u20131483. https:\/\/doi.org\/10.1002\/jpen.2040.","journal-title":"Journal of Parenteral and Enteral Nutrition."},{"key":"9656_CR55","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Office of Communications, Division of Drug Information; 12\/2009."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09656-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09656-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09656-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:26:43Z","timestamp":1783909603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09656-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9656"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09656-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SB, RL, LLK, and PM are employed by Adelphi Values which received payment from VectivBio AG to support the research activities presented in this manuscript. CL was employed by Adelphi Values at the time of the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval for the patient interviews was obtained from Sterling IRB and WCG IRB. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}